S&P 및 Nasdaq 내재가치 문의하기

111, Inc. YI NASDAQ

NASDAQ Global Market • Healthcare • Medical - Pharmaceuticals • CN • USD

SharesGrow Score
29/100
1/5 Pass
SharesGrow Intrinsic Value
$32.89
+383%

111, Inc. (YI) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.

애널리스트 추정 주당순이익(EPS) $3.57 및 매출 $2.12B 다음 회계연도.

주당순이익(EPS) 실적 추이: 2024: 실적 $-7.52 vs 추정 $3.57 (하회 -310.8%). 애널리스트 정확도: 0%.

EPS 전망 — YI

0%
Analyst Accuracy
Inaccurate
1 year compared
Actual vs Estimate
2024 Actual –$7.52 vs Est $3.57 ▼ 147.4% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect the company to turn profitable.

매출 전망 — YI

15%
Analyst Accuracy
Inaccurate
1 year compared
Actual vs Estimate
2024 Actual $14.401B vs Est $2.122B ▲ 85.3% off
Revenue Trend
Analysts expect stable revenue going forward.
문의하기
🎓
SharesGrow 아카데미
내재가치 계산법과 저평가 종목 찾기를 배우세요.
주간 라이브 세션
메시지 보내기